Loading…
Loading grant details…
| Funder | Health Commission of Guangxi Zhuang Autonomous Region |
|---|---|
| Recipient Organization | Government of Laos |
| Country | Lao People's Democratic Republic |
| Start Date | Jan 01, 2019 |
| End Date | Oct 03, 2026 |
| Duration | 2,832 days |
| Number of Grantees | 1 |
| Roles | Recipient |
| Data Source | AidData Chinese Aid |
| Grant ID | 107609 |
In 2019, the First Affiliated Hospital of Guangxi Medical University and Mittaphab Hospital in Vientiane signed a cooperation agreement focused on the treatment of thalassemia, a hereditary blood disorder.
Under this agreement, the Health Commission of Guangxi Zhuang Autonomous Region dispatched a medical team to Mittaphab Hospital to provide specialized treatment and training support.
By 2022, the Chinese medical team was actively working in Vientiane, where they treated approximately 300 Lao patients with thalassemia.
In addition to providing direct medical care, the team worked alongside Lao doctors to transfer knowledge and skills, with the aim of strengthening Mittaphab Hospital’s long-term treatment capacity.
Reports confirm that the team continued its work at the hospital throughout 2023, offering both patient treatment and professional training for local staff.
1. It is unclear when the medical team was first sent to Laos, although sources referenced the team's work in 2022 and their continued presence at the hospital in 2023.
Government of Laos
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant